Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

Objective: The aim of this analysis was to assess the safety profile of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor (SSRI) antidepressants. Methods: A pooled analysis was conducted on data obtained from the integrated safety database of edivoxetine as adjunctive...

Full description

Bibliographic Details
Main Authors: James M Martinez, Margaret B Ferguson, Beth A Pangallo, Tina M Oakes, JonDavid Sparks, Mary Anne Dellva, Qi Zhang, Peng Liu, Mark Bangs, Jonna Ahl, Celine Goldberger
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2015-05-01
Series:Drugs in Context
Subjects:
norepinephrine reuptake inhibitor
serotonin reuptake inhibitor
second-generation antidepressive agent
major depressive disorder
adjunctive therapy
drug safety
drug tolerability
Online Access:http://www.drugsincontext.com/safety-tolerability-edivoxetine-adjunctive-treatment-selective-serotonin-reuptake-inhibitor-antidepressants-patients-major-depressive-disorder/

Internet

http://www.drugsincontext.com/safety-tolerability-edivoxetine-adjunctive-treatment-selective-serotonin-reuptake-inhibitor-antidepressants-patients-major-depressive-disorder/

Similar Items